You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Suppliers and packagers for generic pharmaceutical drug: NYSTATIN; TRIAMCINOLONE ACETONIDE


✉ Email this page to a colleague

« Back to Dashboard


NYSTATIN; TRIAMCINOLONE ACETONIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Alembic NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide CREAM;TOPICAL 214090 ANDA Alembic Pharmaceuticals Limited 46708-606-15 1 TUBE in 1 CARTON (46708-606-15) / 15 g in 1 TUBE 2025-04-08
Alembic NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide CREAM;TOPICAL 214090 ANDA Alembic Pharmaceuticals Limited 46708-606-30 1 TUBE in 1 CARTON (46708-606-30) / 30 g in 1 TUBE 2025-04-08
Alembic NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide CREAM;TOPICAL 214090 ANDA Alembic Pharmaceuticals Limited 46708-606-60 1 TUBE in 1 CARTON (46708-606-60) / 60 g in 1 TUBE 2025-04-08
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drugs: NYSTATIN and TRIAMCINOLONE ACETONIDE

Last updated: July 29, 2025


Introduction

The pharmaceutical industry relies heavily on a complex network of suppliers for active pharmaceutical ingredients (APIs) and excipients. For drugs like Nystatin and Triamcinolone Acetonide, which are widely used for their antifungal and anti-inflammatory properties respectively, ensuring a robust and compliant supplier base is crucial for manufacturing continuity, regulatory compliance, and product quality. This article provides an analysis of key global suppliers for these two drugs, highlighting the landscape, procurement considerations, and strategic sourcing insights.


Overview of Nystatin and Triamcinolone Acetonide

Nystatin is an antifungal polyene antibiotic predominantly used in topical and oral formulations to combat candidiasis. The API manufacturing process involves complex fermentation techniques using Streptomyces noursei.

Triamcinolone Acetonide is a synthetic corticosteroid employed in various topical, injectable, and intra-articular therapies. Its chemical synthesis entails multiple steps, often involving specialized chemical synthesis facilities.

Both drugs are included on the World Health Organization (WHO) Model List of Essential Medicines, underscoring their importance and broad manufacturing demand globally.


Global Supply Landscape for Nystatin

Major API Manufacturers

  1. Sandoz (Novartis AG)
    As part of Novartis, Sandoz is a leading producer of generic pharmaceuticals and APIs, including Nystatin. The company operates multiple fermentation plants across Europe and Asia, employing state-of-the-art microbiology protocols to ensure high-quality API production.

  2. Laclede, Inc.
    Specializes in the fermentation and bulk manufacturing of Nystatin, primarily serving the U.S. and European markets. The company emphasizes compliance with cGMP standards, offering reliable supply chains.

  3. Riedel-de Haën (Merck KGaA)
    Known for its extensive chemical synthesis and fermentation capacity, Merck supplies pharmaceutical-grade Nystatin globally. Their European facilities cater to regional and export requirements with strict quality controls.

  4. Aurobindo Pharma
    An Indian API manufacturer with growing global footprint, Aurobindo produces Nystatin API, targeting both domestic and export markets. Their integrated manufacturing process adheres to international standards, including USFDA and EMA guidelines.

  5. Hubei Xiangyun Pharmaceutical Co., Ltd. (China)
    Chinese API producers like Hubei Xiangyun have ramped up fermentation capacity for Nystatin, driven by increasing demand in Asia and Africa. These manufacturers often offer competitive pricing with rapid lead times.

Key Procurement Considerations

  • Regulatory Compliance: Ensuring suppliers meet cGMP standards and can provide Certificates of Analysis (CoA) compatible with target markets (e.g., US, EU, WHO prequalification).

  • Fermentation Capabilities: Nystatin production hinges on microbial fermentation, demanding specialized infrastructure and quality assurance.

  • Supply Stability: Suppliers with diversified manufacturing sites mitigate risks related to geopolitical, environmental, or supply chain disruptions.

  • Pricing and Lead Times: Competitive pricing, especially from Indian and Chinese manufacturers, often influences procurement decisions.


Global Supply Landscape for Triamcinolone Acetonide

Leading API Producers

  1. Hexal (Sandoz)
    Sandoz's German facility is recognized for its high-quality Triamcinolone Acetonide production, supported by advanced synthesis processes that ensure stereochemical purity.

  2. Hainan Yiling Pharmaceutical Co., Ltd. (China)
    A major Chinese manufacturer, Yiling supplies Triamcinolone Acetonide widely across Asia and emerging markets, offering cost-effective solutions compliant with international standards.

  3. BASF SE
    While primarily a chemical company, BASF’s custom synthesis services include corticosteroids like Triamcinolone Acetonide, often supplied as intermediates or finished APIs to licensed manufacturers worldwide.

  4. Sinopharm Chemical Reagent Co., Ltd. (China)
    Known for bulk pharmaceutical chemicals, Sinopharm provides Triamcinolone Acetonide API, with an emphasis on affordability and compliance with Chinese and international standards.

  5. Dr. Reddy’s Laboratories (India)
    Reddy’s manufacturing facilities produce Triamcinolone Acetonide API targeting regional markets in Asia, Africa, and Latin America, emphasizing cost-efficiency and regulatory adherence.

Strategic Procurement Factors

  • Synthesis Expertise: High-stability chemical synthesis processes with minimal impurities are critical. Suppliers with proven R&D capabilities are preferred.

  • Regulatory Approvals: Suppliers with established registration with major health authorities facilitate faster market access.

  • Manufacturing Capacity: Consistent supply is essential for formulations with high demand, making capacity and scalability vital factors.

  • Cost & Lead Time: Balancing quality, compliance, and cost remains core to successful sourcing.


Regional and Regulatory Dynamics

The landscape of pharmaceutical supplier selection is increasingly influenced by regional regulatory policies. The US FDA, EMA, and WHO prequalification programs assess API manufacturers’ compliance, impacting procurement choices.

In regions like Asia and Africa, local manufacturers that meet international standards are gaining prominence, driven by their competitive pricing and geographical proximity. Conversely, global majors maintain dominance in regulated markets through stringent quality assurances and a track record of compliance.


Emerging Trends and Future Outlook

  • Vertical Integration & Contract Manufacturing: Companies increasingly prefer vertical integration or partnerships to streamline supply chains. Contract manufacturing organizations (CMOs) with cGMP facilities are pivotal in supporting API supply.

  • Supply Chain Diversification: To mitigate disruptions, pharmaceutical companies diversify their supplier base, sourcing from multiple regions and manufacturers.

  • Investment in Technology: Suppliers investing in cutting-edge fermentation and chemical synthesis technologies enhance API purity and yield, aligning with stringent regulatory standards.

  • Regulatory Harmonization: Ongoing efforts toward harmonizing regulatory standards facilitate cross-border API supply, expanding supplier options.


Conclusion

The supply of Nystatin and Triamcinolone Acetonide hinges on a select group of global manufacturers with strong regulatory credibility, advanced manufacturing processes, and adequate capacity. Procurement strategies should prioritize suppliers with proven compliance, scalable production capabilities, and diversified geographic presence to ensure uninterrupted supply and regulatory compliance.


Key Takeaways

  • Diverse sourcing is critical: Leverage suppliers from regions like Europe, North America, India, and China to mitigate geopolitical and market risks.
  • Regulatory alignment matters: Choose manufacturers with established compliance credentials (e.g., USFDA, EMA, WHO prequalification) to expedite approval processes.
  • Technological capabilities influence quality: Prioritize suppliers with innovative fermentation and chemical synthesis technologies that ensure API purity and consistency.
  • Supply chain resilience is essential: Establish relationships with multiple suppliers to prevent shortages and support business continuity.
  • Due diligence reduces risk: Conduct comprehensive audits and review historical compliance records before supplier onboarding.

FAQs

1. How do I verify the compliance of Nystatin and Triamcinolone Acetonide suppliers?
Verification involves reviewing certifications such as cGMP, USFDA, EMA approvals, and WHO prequalifications. Audits, site visits, and co-analysis reports also ensure adherence to quality standards.

2. What are the primary regions for sourcing these APIs?
Major APIs are sourced from Europe (Germany, Switzerland), North America (USA), India, and China, offering a mix of high-quality, cost-efficient, and rapidly available options.

3. How does regional regulation impact API procurement?
Regulatory requirements influence supplier qualification; suppliers must meet regional standards relevant to the target market, impacting approval timelines and market access.

4. Are there challenges associated with sourcing from Chinese and Indian manufacturers?
Challenges include variable quality control, intellectual property concerns, and regulatory compliance. Engaging with reputable, certified suppliers mitigates these risks.

5. What trends are shaping the future API supply chain for these drugs?
Increasing automation, technological innovation, supply chain diversification, and regulatory harmonization are shaping a more resilient, compliant API supply landscape.


References

  1. WHO Model List of Essential Medicines. (2023). World Health Organization.
  2. US Food and Drug Administration (FDA). API Supplier Verification Program.
  3. European Medicines Agency (EMA). Good Manufacturing Practice (GMP) Guidelines.
  4. Industry reports on API manufacturing, 2022-2023.
  5. Company websites and official filings of key API manufacturers.

By understanding the current supplier landscape and aligning procurement strategies accordingly, pharmaceutical companies can secure high-quality APIs for Nystatin and Triamcinolone Acetonide, ensuring consistent product quality and regulatory compliance.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.